Drugs and memory disorders in human aging.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000375:Aging; D000661:Amphetamine / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001143:Arousal / Q000187:drug effects; D002110:Caffeine / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000494:pharmacology / Q000627:therapeutic use; D002560:Cerebrovascular Circulation; D002648:Child; D006213:Hallucinogens / Q000627:therapeutic use; D006801:Humans; D006931:Hyperbaric Oxygenation; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007858:Learning / Q000187:drug effects; D008569:Memory Disorders / Q000188:drug therapy* / Q000628:therapy; D008875:Middle Aged; D009538:Nicotine / Q000494:pharmacology; D009747:Nutritional Physiological Phenomena; D010277:Parasympathomimetics / Q000494:pharmacology; D011343:Procaine / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D000927:Anticonvulsants; D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D006213:Hallucinogens; D006993:Hypnotics and Sedatives; D010277:Parasympathomimetics; D013566:Sympathomimetics; D002110:Caffeine; D011343:Procaine; D009538:Nicotine; D000661:Amphetamine